EPTIS
BAM Logo

Clinical PT - Immunology

[EP Clínico - Imunologia]

EPTIS factsheet 126080 | Last revision 2016-07-13 | URL: https://www.eptis.bam.de/pts126080 https://www.eptis.bam.de/pts126080

PT provider
PT provider ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda
Based in Brazil
Language(s) Portuguese/ English / Spanish
Remarks
Keywords
Product groups Health care / medical devices
Human test material
Laboratory / scientific equipment
Process control systems
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilised human serum ASO or ASLO (Anti-Streptolysin O) Routine methods of participants
Rheumatoid factor antibody (RF) Routine methods of participants
C-Reactive Protein (CRP) Routine methods of participants
TPO (Thyroperoxidase) Routine methods of participants
CMV IgG antibodies (Cytomegalovirus) Routine methods of participants
CMV IgM antibodies (Cytomegalovirus) Routine methods of participants
Anti-HAV IgG Routine methods of participants
Anti-HAV IgM Routine methods of participants
Anti-HBc IgG Routine methods of participants
Anti-HBc IgM Routine methods of participants
Rubella IgG Routine methods of participants
Rubella IgM Routine methods of participants
Toxoplasmosis IgG Routine methods of participants
Toxoplasmosis IgM Routine methods of participants
Leptospirosis IgG Routine methods of participants
Leptospirosis IgM Routine methods of participants
Cardiolipin IgG Routine methods of participants
Cardiolipin IgM Routine methods of participants
CCP Antibody Routine methods of participants
Mumps IgG (Caxumba) Routine methods of participants
Mumps IgM (Caxumba) Routine methods of participants
Chlamydia IgG Routine methods of participants
Chlamydia IgM Routine methods of participants
Herpes I/II IgG Routine methods of participants
Herpes I/II IgM Routine methods of participants
Herpes I/II, total Routine methods of participants
Herpes I IgG Routine methods of participants
Herpes I IgM Routine methods of participants
Herpes I, total Routine methods of participants
Herpes II IgG Routine methods of participants
Herpes II IgM Routine methods of participants
Herpes II, total Routine methods of participants
Measles IgG (Sarampo) Routine methods of participants
Measles IgM (Sarampo) Routine methods of participants
Syphilis IgG Routine methods of participants
Syphilis IgM Routine methods of participants
Epstein-Barr IgM Routine methods of participants
Epstein-Baar VCA IgG/IgM Routine methods of participants
Epstein-Barr Anti-EBNA IgG/IgM Routine methods of participants
Epstein-Barr Anti-EA IgG/IgM Routine methods of participants
Zika Vírus IgG Routine methods of participants
Zika Vírus IgM Routine methods of participants
Chikungunya IgG Routine methods of participants
Chikungunya IgM Routine methods of participants
Aims of the PT scheme
Target group of participants No restrictions.
Linked to specific legislation / standards ABNT NBR ISO/IEC 17043
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Variable costs. For this information, please contact ControlLab.
Regularly operated Yes (4 rounds per year)
Year of first operation 1977
Contact details of the PT provider
Provider Contact person
ControlLab Controle de Qualidade para Laboratórios Ltda
Rua Ana Neri 416 Benfica
20911-442 Rio de Janeiro
Brazil

Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Web: http://www.controllab.com.br http://www.controllab.com.br
Vinicius Biasoli
Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Email: vinicius.biasoli@controllab.com.br vinicius.biasoli@controllab.com.br
If you find any mistakes please contact the responsible EPTIS coordinator in Brazil, Mr Paulo Roberto da Fonseca Santos. Mr Paulo Roberto da Fonseca Santos.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21